FDA Approved: YUPELRI — Original Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved YUPELRI (revefenacin) from Viatris Specialty LLC as an original NDA approval for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Yupelri (revefenacin)

Snippet

ORIG AP for YUPELRI (REVEFENACIN)